Home / Epinephrine / United States
US ATC C01CA24 · updated 2 Nov 2026
Epinephrine shortage in United States
Is there an Epinephrine shortage in United States?
Yes. As of 2 Nov 2026, 2 Epinephrine products are reported short in United States, the first since 7 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Ireland, Austria, Switzerland, Czechia, Norway, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-01) discontinuation | Hospira, Inc., a Pfizer Company | 7 Nov 2025 | not given | Not stated |
| US | Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-10) discontinuation | Hospira, Inc., a Pfizer Company | 7 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).